How Investors May Respond To Ameren (AEE) Raising Earnings Guidance on Strong Q3 Results and 2026 Outlook

• Ameren Corporation recently reported third quarter 2025 results, delivering year-over-year revenue growth to US$2.70 billion and lifting its full-year GAAP earnings guidance to a range of US$5.08 to US$5.28 per share, while also issuing 2026 guidance between US$5.25 and US$5.45 per share.
• This strong performance was underpinned by increased infrastructure investments, new electric service rates, and favorable weather, with both revenue and earnings per share surpassing analyst expectations.
• Given Ameren's raised earnings guidance and ongoing infrastructure investments, we'll explore how these developments reinforce its long-term growth narrative.

This technology could replace computers: discover 27 stocks that are working to make quantum computing a reality.

Ameren Investment Narrative Recap

To be a shareholder in Ameren today, you need to believe that robust infrastructure investment and rising demand, especially from data center expansion and electrification trends, will unlock sustainable long-term earnings growth, despite ongoing regulatory risks. The company's recent earnings beat and raised guidance are encouraging for short-term momentum, as they reinforce confidence in Ameren’s ability to recover investment costs through rates and maintain strong earnings, though regulatory approval delays remain the biggest risk; the latest results do not materially reduce this risk.

Among recent announcements, Ameren’s updated 2025 and new 2026 earnings guidance stands out as most relevant: by lifting its 2025 GAAP EPS range and setting a stronger baseline for 2026, management is signaling confidence in continued operational performance, supported by higher infrastructure spending and new service rates, both critical short-term catalysts for revenue and earnings resilience amid evolving regulatory dynamics.

By contrast, investors should be aware of the risk that regulatory lag or shifting policy support for infrastructure investments could limit Ameren’s ability to recover its…

Read the full narrative on Ameren (it's free!)

Ameren's narrative projects $9.7 billion revenue and $1.7 billion earnings by 2028. This requires 6.2% yearly revenue growth and a $0.5 billion earnings increase from $1.2 billion today.

Uncover how Ameren's forecasts yield a $111.43 fair value, a 6% upside to its current price.

Exploring Other Perspectives

Two Simply Wall St Community fair value estimates range from US$85.94 to US$111.43 per share. While the community offers diverse viewpoints, ongoing dependency on timely regulatory approvals remains central to Ameren’s future returns.

Explore 2 other fair value estimates on Ameren - why the stock might be worth 18% less than the current price!

Build Your Own Ameren Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

• A great starting point for your Ameren research is our analysis highlighting 2 key rewards and 3 important warning signs that could impact your investment decision.
• Our free Ameren research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Ameren's overall financial health at a glance.

Interested In Other Possibilities?

Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:

• AI is about to change healthcare. These 32 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• The end of cancer? These 29 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's.
• These 13 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com